| Literature DB >> 35765392 |
Yoshihiro Aoki1, Toshiyuki Tanaka1, Naoto Mizushiro1, Katsuhiko Kitazawa2.
Abstract
Varicella-zoster virus (VZV) may cause aseptic meningitis in the pediatric age group. We describe a pediatric case of aseptic meningitis with a substantial increase of the paired serum antibody to VZV in which the child did not have skin rash during the course of illness. The patient was a 13-year-old boy without any history of exposure to VZV who was admitted with headache, vomiting, and low-grade fever. He had received one dose of varicella vaccine derived from the Oka/Biken strain (vOka) at the age of one year. Cerebrospinal fluid (CSF) analysis on admission revealed an elevated white blood cell count at 609/mm3 with 99.6% mononuclear cells. As his symptoms resolved after lumbar puncture alone, he was discharged on the seventh day of hospitalization without receiving any specific medication. Serum VZV-IgG titer was found to be substantially elevated after two weeks. VZV infection and reactivations associated with vaccination, as well as past infections, should be included in the differential diagnoses of pediatric aseptic meningitis, even in the absence of skin rash in the entire course. Polymerase chain reaction (PCR) testing for VZV DNA in CSF should be performed in all cases, if available.Entities:
Keywords: adolescent medicine; aseptic meningitis; serology; varicella vaccine; varicella-zoster virus
Year: 2022 PMID: 35765392 PMCID: PMC9233734 DOI: 10.7759/cureus.25375
Source DB: PubMed Journal: Cureus ISSN: 2168-8184
The results of complete hemogram, biochemistry, serum electrolytes, and blood gas on admission
| Test | Reference range | Result |
| Hemoglobin (g/dL) | 13.7–16.8 | 15.7 |
| White blood cell count (/µL) | 3.3–8.6 × 103 | 7.3 × 103 |
| Differential (%) | ||
| Neutrophils | 45.0–72.0 | 67.8 |
| Eosinophils | 0.8–8.4 | 2.3 |
| Platelet count (/µL) | 15.8–34.8 × 104 | 26.8 × 104 |
| C-reactive protein (mg/dL) | 0–0.14 | 0.02 |
| Albumin (g/L) | 4.1–5.1 | 4.7 |
| Globulin (g/L) | 2.5–3.0 | 2.6 |
| Total bilirubin (mg/dL) | 0.4–1.5 | 0.8 |
| Aspartate aminotransferase (U/L) | 13–30 | 18 |
| Alanine aminotransferase (U/L) | 10–42 | 12 |
| Creatinine kinase (U/L) | 59–248 | 70 |
| Urea nitrogen (mg/dL) | 8–20 | 11.7 |
| Creatinine (mg/dL) | 0.40–0.81 | 0.58 |
| Sodium (mEq/L) | 138–145 | 140 |
| Potassium (mEq/L) | 3.6–4.8 | 3.9 |
| Chloride (mEq/L) | 101–108 | 102 |
| Calcium (mg/dL) | 8.8–10.1 | 9.8 |
| Glucose (mg/dL) | 73–200 | 91 |
| pH | 7.35–7.45 | 7.393 |
| Bicarbonate (mmol/L) | 20.0–26.0 | 19.9 |
| Base excess (mmol/L) | -3.0–3.0 | -4.0 |
| Lactate (mmol/L) | 0.4–1.8 | 1.99 |
Figure 1Brain magnetic resonance imaging (MRI) performed on admission
(A) Diffusion-weighted MRI and (B) fluid-attenuated inversion recovery (FLAIR) MRI showing no remarkable findings